Assessment shows improved agreement on OCT biomarkers in AMD, suggesting strengthened clinical utility with consensus protocols.
Implementing consensus definitions and protocols can improve agreement and strengthen the clinical utility of OCT biomarkers in AMD.
No takes yet. Share an insight, caveat, or question.
Trinh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: